Effects of rosiglitazone treatment on the pentose phosphate pathway and glutathione-dependent enzymes in liver and kidney of rats fed a high-fat diet

Current Therapeutic Research - Clinical and Experimental

Volumn 65, Issue 1, 2004, Pages 79-89

  Akbay, Esen ^a   Nuray Ulusu, Nuriye ^b   Töröner, Füsun ^c   Ayvaz, Göksun ^c   Taneri, Ferit ^c   Aktürk, Müjde ^c   Arslan, Metin ^c   Karasu, Çimen ^c  

^a MERSIN UNIVERSITY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

^c GAZI UNIVERSITY   (Turkey)

Author keywords

glutathione dependent metabolism; high fat diet; metabolic syndrome; obesity; pentose phosphate pathway; rat; rosiglitazone

Indexed keywords

GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; KIDNEY ENZYME; LIVER ENZYME; PHOSPHOGLUCONATE DEHYDROGENASE; ROSIGLITAZONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; ISOLATED LIVER; ISOLATED ORGAN; KIDNEY; LIPID DIET; LIVER; MALE; METABOLIC SYNDROME X; NONHUMAN; OBESITY; PENTOSE PHOSPHATE CYCLE; PRIORITY JOURNAL; RAT; SPECTROPHOTOMETRY; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 3242720447     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(04)90007-0     Document Type: Article

References (35)

1. Trevisan M., Browne R., Ram M., et al. Correlates of markers of oxidative status in the general population. Am J Epidemiol. 154:2001;348-356
2. Sevanian A., Hochstein P. Mechanisms and consequences of lipid peroxidation in biological systems. Annu Rev Nutr. 5:1985;365-390
3. Basaga H.S. Biochemical aspects of free radicals. Biochem Cell Biol. 68:1990;989-998
4. Hayes J.D., McLellan L.I. Glutathione and glutathione-dependent enzymes represent a coordinately regulated defence against oxidative stress. Free Radic Res. 31:1999;273-300
5. Deneke S.M., Fanburg B.L. Regulation of cellular glutathione. Am J Physiol. 257:1989;L163-L173
6. Wood T. Physiological functions of the pentose phosphate pathway. Cell Biochem Funct. 4:1986;241-247
7. Tallman D.L., Taylor C.G. Effects of dietary fat and zinc on adiposity, serum leptin and adipose fatty acid composition in C57BL/6J mice. J Nutr Biochem. 14:2003;17-23
8. Chen L.C., Boissonneault G., Hayek M.G., Chow C.K. Dietary fat effects on hepatic lipid peroxidation and enzymes of H202 metabolism and NADPH generation. Lipids. 28:1993;657-662
9. Watson A.M., Poloyac S.M., Howard G., Blouin R.A. Effect of leptin on cytochrome P-450, conjugation, and antioxidant enzymes in the ob/ob mouse. Drug Metab Dispos. 27:1999;695-700
10. Saltiel A.R., Olefsky J.M. Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes. 45:1996;1661-1669
11. Willson T.M., Lambert M.H., Kliewer S.A. Peroxisome proliferator- activated receptor gamma and metabolic disease. Annu Rev Biochem. 70:2001;341-367
12. Malinowski J.M., Bolesta S. Rosiglitazone in the treatment of type 2 diabetes mellitus: A critical review. [published correction appears in Clin Ther. 2001;23:309] Clin Ther. 22:2000;1151-1168
13. Chen L.C., Tatum V., Glauert H.P., Chow C.K. Peroxisome proliferator perfluorodecanoic acid alters glutathione and related enzymes. J Biochem Mol Toxicol. 15:2001;107-113
14. O'Brien M.L., Twaroski T.P., Cunningham M.L., et al. Effects of peroxisome proliferators on antioxidant enzymes and antioxidant vitamins in rats and hamsters. Toxicol Sci. 60:2001;271-278
15. Narayanan P.K., Hart T., Elcock F., et al. Troglitazone-induced intracellular oxidative stress in rat hepatoma cells: A flow cytometric assessment. Cytometry. 52A:2003;28-35
16. Lennon A.M., Ramauge M., Dessouroux A., Pierre M. MAP kinase cascades are activated in astrocytes and preadipocytes by 15-deoxy-Delta(12-14)- prostaglandin J(2) and the thiazolidinedione ciglitazone through peroxisome proliferator activator receptor gamma-independent mechanisms involving reactive oxygenated species. J Biol Chem. 277:2002;29681-29685
17. Ulusu N.N., Kus M.S., Acan N.L., Tezcan E.F. A rapid method for the purification of glucose-6-phosphate dehydrogenase from bovine lens. Int J Biochem Cell Biol. 31:1999;787-796
18. Pearse B.M., Rosemeyer M.A. 6-Phosphogluconate dehydrogenase from human erythrocytes. Methods Enzymol. 41:1975;220-226
19. Habig W.H., Pabst M.J., Jakoby W.B. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem. 249:1974;7130-7139
20. Acan N.L., Tezcan E.F. Sheep brain glutathione reductase: Purification and general properties. FEBS Lett. 250:1989;72-74
21. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:1976;248-254
22. Shapiro R., Nuss M.E., Kaszubska W., et al. Effects of treatment of C57BL/6J mice fed high fat vs. low fat diets with metformin or rosiglitazone on adiposity, food intake, hyperglycemia and insulin resistance. Poster presented at: 83rd Annual Meeting of the Endocrine Society. 2001;. Denver, Colo.
23. Pickavance L.C., Tadayyon M., Widdowson P.S., et al. Therapeutic index for rosiglitazone in dietary obese rats: Separation of efficacy and haemodilution. Br J Pharmacol. 128:1999;1570-1576
24. Carey D.G., Galloway G., Dodrell D., et al. Rosiglitazone reduces hepatic fat and increases subcutaneous but not intra-abdominal fat depots. Diabetologia. 43:(Suppl 1):2000;A181. Abstract
25. Ayala A., Fabregat I., Machado A. The role of NADPH in the regulation of glucose-6- phosphate and 6-phosphogluconate dehydrogenases in rat adipose tissue. Mol Cell Biochem. 105:1991;1-5
26. Ashby J., Brady A., Elcombe C.R., et al. Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis. Hum Exp Toxicol. 13:(Suppl 2):1994;S1-S117
27. Reddy J.K., Warren J.R., Reddy M.K., Lalwani N.D. Hepatic and renal effects of peroxisome proliferators: Biological implications. Ann NY Acad Sci. 386:1982;81-110
28. Tettey J.N., Maggs J.L., Rapeport W.G., et al. Enzyme-induction dependent bioactivation of troglitazone and troglitazone quinone in vivo. Chem Res Toxicol. 14:2001;965-974
29. Lloyd S., Hayden M.J., Sakai Y., et al. Differential in vitro hepatotoxicity of troglitazone and rosiglitazone among cryopreserved human hepatocytes from 37 donors. Chem Biol Interact. 142:2002;57-71
30. Teruel T., Hernandez R., Benito M., Lorenzo M. Rosiglitazone and retinoic acid induce uncoupling protein-1 (UCP-1) in a p38 mitogen-activated protein kinase-dependent manner in fetal primary brown adipocytes. J Biol Chem. 278:2003;263-269
31. Lawrence R.A., Parkhill L.K., Burk R.F. Hepatic cytosolic non selenium-dependent glutathione peroxidase activity: Its nature and the effect of selenium deficiency. J Nutr. 108:1978;981-987
32. Ashida H., Nakai R., Kanazawa K., Danno G. Xenobiotic tolerance of primary cultured hepatocytes in rats fed a high-fat or high-protein diet. J Nutr Sci Vitaminol (Tokyo). 44:1998;89-102
33. York J.L., Wolff G.L. Glutathione S-transferase activity and isoenzyme concentrations in obese AVY/a and lean a/a mice. Proc Soc Exp Biol Med. 205:1994;186-189
34. Barnett C.R., Abbott R.A., Bailey C.J., et al. Cytochrome P-450-dependent mixed-function oxidase and glutathione S-transferase activities in spontaneous obesity-diabetes. Biochem Pharmacol. 43:1992;1868-1871
35. Salazar D.E., Sorge C.L., Jordan S.W., Corcoran G.B. Obesity decreases hepatic glutathione concentrations and markedly potentiates allyl alcohol-induced periportal necrosis in the overfed rat. Int J Obes Relat Metab Disord. 18:1994;25-33